RELATED STUDY
Therapeutic Potential Of Non-Psychotropic Cannabidiol In Ischemic Stroke
Key Findings: CBD exerts positive pharmacological effects in ischemic stroke and other chronic diseases, including Parkinson’s disease, Alzheimer’s disease, and rheumatoid arthritis. The cerebroprotective action of CBD is CB1 receptor-independent, long-lasting, and has potent anti-oxidant activity.
Type of Study: Meta-analysis
Study Result: Positive
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Not Applicable
Chemotype: Chemotype III
Form of Administration: Not Applicable
Receptors Studied: CB1, CB2
Study Location(s): Japan
Year of Pub: 2010
Link to study